BriaCell Therapeutics (BCTX) Liabilities and Shareholders Equity (2019 - 2026)
BriaCell Therapeutics (BCTX) reported Liabilities and Shareholders Equity of $27.07 million for fiscal Q3 2026 (quarter ended Apr 30, 2026), up 59.2% from $17 million a year earlier but down 19.4% from the prior quarter.
Powered by 
Analysis
BriaCell Therapeutics (BCTX) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends
At the end of FY2025 (ended Jul 31, 2025), BriaCell Therapeutics posted Liabilities and Shareholders Equity of $21.65 million, up 268.7% from FY2024.
- Liabilities and Shareholders Equity has a five-year compound annual growth rate of 114.5% (FY2020 to FY2025).
- By fiscal year, Liabilities and Shareholders Equity came in at $5.87 million in FY2024 (-78.4%), $27.16 million in FY2023 (-36.2%), $42.58 million in FY2022 (-26.6%) and $58.04 million in FY2021.
- Five-year quarterly Liabilities and Shareholders Equity spans a low of $5.87 million in fiscal Q4 2024 and a high of $58.04 million in fiscal Q4 2021.
- Year over year, Liabilities and Shareholders Equity has now increased in each of the last five quarters, with growth averaging 80.1% over the last eight quarters.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was fiscal Q4 2025 (growth of 268.7%); the low point was fiscal Q3 2024 (a decline of 79.1%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $33.59 million (Q2 2026), $13.08 million (Q1 2026) and $21.65 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | BriaCell Therapeutics | 31.03 Mn | 30.38 Mn | - | 27.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 27.07 Mn |
| Jan 31, 2026 | 33.59 Mn |
| Oct 31, 2025 | 13.08 Mn |
| Jul 31, 2025 | 21.65 Mn |
| Apr 30, 2025 | 17.00 Mn |
| Jan 31, 2025 | 9.36 Mn |
| Oct 31, 2024 | 10.41 Mn |
| Jul 31, 2024 | 5.87 Mn |
| Apr 30, 2024 | 6.20 Mn |
| Jan 31, 2024 | 12.23 Mn |
| Oct 31, 2023 | 18.62 Mn |
| Jul 31, 2023 | 27.16 Mn |
| Apr 30, 2023 | 29.72 Mn |
| Jan 31, 2023 | 34.16 Mn |
| Oct 31, 2022 | 38.45 Mn |
| Jul 31, 2022 | 42.58 Mn |
| Apr 30, 2022 | 46.46 Mn |
| Jan 31, 2022 | 48.55 Mn |
| Jul 31, 2021 | 58.04 Mn |
| Jul 31, 2020 | 469,291.47 |
API Access
BriaCell Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "BCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();